Advertisement

Innovative Trauma Care raises $3.64 million in Series A financing to commercialize its 1st product.

Innovative Trauma Care raised $3.6 million in a Series A financing round in support of commercialization of the company's 1st product, a device used to treat massive hemorrhaging.

The company's It ClampTM hemorrhage control system creates a temporary pool of blood under pressure that forms a stable clot until a wound is surgically repaired, capable of controlling bleeding in as little as 5 seconds, according to the press release.

Advertisement
Advertisement